Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Abbey, Ashkan M
ARCHER II, NCT06510816: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)	Recruiting	3	630	US	ANX007, Sham Administration	Annexon, Inc.	Geographic Atrophy	10/26	10/27
NCT06181227: A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema	Terminated	2	21	US	AVD-104	Aviceda Therapeutics, Inc.	Diabetic Macular Edema, Diabetic Retinopathy	04/24	04/24
SIGLEC, NCT05839041: A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)	Active, not recruiting	2	300	US	AVD-104, Avacincaptad	Aviceda Therapeutics, Inc.	Geographic Atrophy of the Macula, Macular Degeneration	09/25	09/26